Edition:
United States

DiaSorin ‍completes acquisition of Elisa immunodiagnostic business portfolio​


Friday, 29 Sep 2017 06:19am EDT 

Sept 29 (Reuters) - DIASORIN SPA ::‍COMPLETES ACQUISITION OF ELISA IMMUNODIAGNOSTIC BUSINESS PORTFOLIO AND ASSOCIATED ASSETS FROM SIEMENS HEALTHINEERS​.